Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (331-340 of 652) with videos related to

Pageof 66
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2020
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative ColitisSilvio Danese, Markus F Neurath, Adam Kopoń, et al.
Oral Oncology|March 3, 2017
Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinomaAlex Panaccione, Yi Zhang, Yanfang Mi, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin AmericaDomingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III TrialsRemo Panaccione, Christopher Ma, Vipul Jairath, et al.
Advances in Therapy|August 10, 2024
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect ComparisonsWalter Reinisch, Gil Y Melmed, Hiroshi Nakase, et al.
Frontiers in Psychiatry|December 19, 2017
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in AdolescentsMarco Di Nicola, Vittoria Rachele Ferri, Lorenzo Moccia, et al.
Structural Dynamics (Melville, N.Y.)|December 15, 2025
A UHV-compatible, time-resolved spontaneous Raman spectrometer for multi-messenger ultrafast studies: Design and applications to photoinduced dynamicsA M Finardi, C Fasolato, A Giugni, et al.
Crohn'S & Colitis 360|June 30, 2026
Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitisChristopher Ma, Eric B Collins, Si-Tien Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Impact of Extended Risankizumab Treatment in Patients With Ulcerative Colitis Who Did Not Respond to Induction TreatmentRemo Panaccione, Gil Y Melmed, David Drobne, et al.
Inflammatory Bowel Diseases|May 20, 2022
Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel DiseaseBradley G Goodyear, Faranak Heidari, Richard J M Ingram, et al.
Pageof 66

Showing results (331-340 of 652) with videos related to

Sort By:
Pageof 66
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2020
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative ColitisSilvio Danese, Markus F Neurath, Adam Kopoń, et al.
Oral Oncology|March 3, 2017
Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinomaAlex Panaccione, Yi Zhang, Yanfang Mi, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin AmericaDomingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III TrialsRemo Panaccione, Christopher Ma, Vipul Jairath, et al.
Advances in Therapy|August 10, 2024
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect ComparisonsWalter Reinisch, Gil Y Melmed, Hiroshi Nakase, et al.
Frontiers in Psychiatry|December 19, 2017
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in AdolescentsMarco Di Nicola, Vittoria Rachele Ferri, Lorenzo Moccia, et al.
Structural Dynamics (Melville, N.Y.)|December 15, 2025
A UHV-compatible, time-resolved spontaneous Raman spectrometer for multi-messenger ultrafast studies: Design and applications to photoinduced dynamicsA M Finardi, C Fasolato, A Giugni, et al.
Crohn'S & Colitis 360|June 30, 2026
Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitisChristopher Ma, Eric B Collins, Si-Tien Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Impact of Extended Risankizumab Treatment in Patients With Ulcerative Colitis Who Did Not Respond to Induction TreatmentRemo Panaccione, Gil Y Melmed, David Drobne, et al.
Inflammatory Bowel Diseases|May 20, 2022
Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel DiseaseBradley G Goodyear, Faranak Heidari, Richard J M Ingram, et al.
Pageof 66